Answers are grounded in this paper and cite their sources.
The incidence of metastatic malignancy of unknown origin was approximately 3 %. The extent of investigation to determine the primary site was strongly influenced by estimating the probability that additional information would significantly change the treatment. Treatment regimens are described.
No takes yet. Share an insight, caveat, or question.
Lleander et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: